Jubilant Pharmova Ltd (NSE:JUBLPHARMA) Share Price

Company Profile

Business description
Jubilant Pharmova Ltd is an integrated pharmaceutical company. The company operates in the following segments; Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation; and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment which specializes in developing, manufacturing, commercializing, and distributing therapeutic agents in the nuclear medicine domain. Geographically, it derives a majority of its revenue from the Americas and Europe and the rest from India and the Rest of the world.
Contact
1A, Sector 16A
NoidaUP201301
IND
T: +91 1204361000
https://www.jubilantpharmova.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
5,547

Recommended

Muse models may just be the spark that the rirm needed in AI model development.

Malik Ahmed Khan, CFA | 13 April 2026

Despite headwinds our long-term outlook is unchanged.

Esther Holloway | 12 April 2026

We think the floundering stock price is not reflective of underlying asset value.

Brian Han | 10 April 2026

Index	Last price	Change	% Change
All Ordinaries	9,113.40	6.40	0.07%
CAC 40	8,197.67	61.93	-0.75%
DAX 40	23,599.08	204.87	-0.86%
Dow JONES (US)	47,570.01	346.56	-0.72%
FTSE 100	10,557.14	43.39	-0.41%
HKSE	25,660.85	232.69	-0.90%
NASDAQ	22,830.33	72.56	-0.32%
Nikkei 225	56,502.77	421.34	-0.74%
NZX 50 Index	13,020.18	161.26	-1.22%
S&P 500	6,795.55	21.34	-0.31%
S&P/ASX 200	8,926.00	14.20	0.16%
SSE Composite Index	3,988.56	2.33	0.06%